Veeva Systems Inc. ( NYSE:VEEV ) recently posted some strong earnings, and the market responded positively. We ...
13h
Zacks Investment Research on MSNWall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
13h
Zacks Investment Research on MSNVeeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should KnowVeeva Systems (VEEV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...
EVERSANA – pharmaphorum's parent company – said it has met the standard to join Veeva's partner programme and will now be ...
Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that ...
Shares of Veeva Systems Inc. (NYSE:VEEV – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...
Research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Veeva Systems in a report released on Wednesday, March 26th. Zacks Research analyst R. Department now ...
Veeva Systems's VEEV short percent of float has fallen 10.0% since its last report. The company recently reported that it has ...
In a report released today, Saket Kalia from Barclays maintained a Buy rating on Veeva Systems (VEEV – Research Report), with a price target of ...
Veeva Systems VEEV has outperformed the market over the past 10 years by 14.57% on an annualized basis producing an average ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
JPMorgan raised the firm’s price target on Veeva (VEEV) to $249 from $218 and keeps a Neutral rating on the shares. Veeva has a substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results